CEN BIOTECH, INC.

Other languages CEN Biotech, Inc.

Equities

CENBF

CA15130L1040

Market Closed - OTC Markets Other stock markets 09:19:14 29/04/2024 pm IST			5-day change	1st Jan Change
0.00738 ^USD	+138.06%		+138.71%	+146.67%

2023	CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer	CI
2022	CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer	30/23/30
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15
CEN Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	23/22/23
CEN Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	21/22/21
CEN Biotech, Inc. Announces Changes to Its Board	22/22/22
CEN Biotech, Inc. Announces Management Changes	19/22/19
CEN Biotech, Inc. Announces Executive Changes	19/22/19
CEN Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/22/15
CEN Biotech, Inc. Auditor Raises 'Going Concern' Doubt	14/22/14
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	20/21/20
Cen Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	13/21/13
Cen Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	13/21/13
Cen Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	13/21/13
Cen Biotech, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	06/20/06
Cen Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	31/20/31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer